However, it is unknown whether broad‐range DUB inhibitor PR‐619 could also significantly inhibit ESCC cell growth via disrupting the dynamic balance of ubiquitin conjugation. This evidence concerns the gene ZUP1 and esophageal squamous cell carcinoma.